Evaluation of the male reproductive toxicity of gallium arsenide

Ernst M. Bomhard, Samuel Monroe Cohen, Heinz Peter Gelbke, Gary M. Williams

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Gallium arsenide is an important semiconductor material marketed in the shape of wafers and thus is not hazardous to the end user. Exposure to GaAs particles may, however, occur during manufacture and processing. Potential hazards require evaluation. In 14-week inhalation studies with small GaAs particles, testicular effects have been reported in rats and mice. These effects occurred only in animals whose lungs showed marked inflammation and also had hematologic changes indicating anemia and hemolysis. The time- and concentration-dependent progressive nature of the lung and blood effects together with bioavailability data on gallium and arsenic lead us to conclude that the testicular/sperm effects are secondary to hypoxemia resulting from lung damage rather than due to a direct chemical effect of gallium or arsenide. Conditions leading to such primary effects are not expected to occur in humans at production and processing sites. This has to be taken into consideration for any classification decision for reproductive toxicity; especially a category 1 according to the EU CLP system is not warranted.

Original languageEnglish (US)
Pages (from-to)77-86
Number of pages10
JournalRegulatory Toxicology and Pharmacology
Volume64
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Toxicity
Gallium
Lung
Arsenic
Processing
Semiconductors
Rats
Hazards
Animals
Blood
Hemolysis
Semiconductor materials
Inhalation
Biological Availability
Spermatozoa
Anemia
Inflammation
gallium arsenide

Keywords

  • Alveolar proteinosis
  • Gallium arsenide
  • Hemolysis
  • Hypoxemia
  • Inhalation
  • Lung inflammation
  • Mouse
  • Rat
  • Semiconductor
  • Testicular atrophy

ASJC Scopus subject areas

  • Toxicology

Cite this

Evaluation of the male reproductive toxicity of gallium arsenide. / Bomhard, Ernst M.; Cohen, Samuel Monroe; Gelbke, Heinz Peter; Williams, Gary M.

In: Regulatory Toxicology and Pharmacology, Vol. 64, No. 1, 01.01.2012, p. 77-86.

Research output: Contribution to journalArticle

Bomhard, Ernst M. ; Cohen, Samuel Monroe ; Gelbke, Heinz Peter ; Williams, Gary M. / Evaluation of the male reproductive toxicity of gallium arsenide. In: Regulatory Toxicology and Pharmacology. 2012 ; Vol. 64, No. 1. pp. 77-86.
@article{341770ec187c4819943b6c91085c0440,
title = "Evaluation of the male reproductive toxicity of gallium arsenide",
abstract = "Gallium arsenide is an important semiconductor material marketed in the shape of wafers and thus is not hazardous to the end user. Exposure to GaAs particles may, however, occur during manufacture and processing. Potential hazards require evaluation. In 14-week inhalation studies with small GaAs particles, testicular effects have been reported in rats and mice. These effects occurred only in animals whose lungs showed marked inflammation and also had hematologic changes indicating anemia and hemolysis. The time- and concentration-dependent progressive nature of the lung and blood effects together with bioavailability data on gallium and arsenic lead us to conclude that the testicular/sperm effects are secondary to hypoxemia resulting from lung damage rather than due to a direct chemical effect of gallium or arsenide. Conditions leading to such primary effects are not expected to occur in humans at production and processing sites. This has to be taken into consideration for any classification decision for reproductive toxicity; especially a category 1 according to the EU CLP system is not warranted.",
keywords = "Alveolar proteinosis, Gallium arsenide, Hemolysis, Hypoxemia, Inhalation, Lung inflammation, Mouse, Rat, Semiconductor, Testicular atrophy",
author = "Bomhard, {Ernst M.} and Cohen, {Samuel Monroe} and Gelbke, {Heinz Peter} and Williams, {Gary M.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.yrtph.2012.06.005",
language = "English (US)",
volume = "64",
pages = "77--86",
journal = "Regulatory Toxicology and Pharmacology",
issn = "0273-2300",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Evaluation of the male reproductive toxicity of gallium arsenide

AU - Bomhard, Ernst M.

AU - Cohen, Samuel Monroe

AU - Gelbke, Heinz Peter

AU - Williams, Gary M.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Gallium arsenide is an important semiconductor material marketed in the shape of wafers and thus is not hazardous to the end user. Exposure to GaAs particles may, however, occur during manufacture and processing. Potential hazards require evaluation. In 14-week inhalation studies with small GaAs particles, testicular effects have been reported in rats and mice. These effects occurred only in animals whose lungs showed marked inflammation and also had hematologic changes indicating anemia and hemolysis. The time- and concentration-dependent progressive nature of the lung and blood effects together with bioavailability data on gallium and arsenic lead us to conclude that the testicular/sperm effects are secondary to hypoxemia resulting from lung damage rather than due to a direct chemical effect of gallium or arsenide. Conditions leading to such primary effects are not expected to occur in humans at production and processing sites. This has to be taken into consideration for any classification decision for reproductive toxicity; especially a category 1 according to the EU CLP system is not warranted.

AB - Gallium arsenide is an important semiconductor material marketed in the shape of wafers and thus is not hazardous to the end user. Exposure to GaAs particles may, however, occur during manufacture and processing. Potential hazards require evaluation. In 14-week inhalation studies with small GaAs particles, testicular effects have been reported in rats and mice. These effects occurred only in animals whose lungs showed marked inflammation and also had hematologic changes indicating anemia and hemolysis. The time- and concentration-dependent progressive nature of the lung and blood effects together with bioavailability data on gallium and arsenic lead us to conclude that the testicular/sperm effects are secondary to hypoxemia resulting from lung damage rather than due to a direct chemical effect of gallium or arsenide. Conditions leading to such primary effects are not expected to occur in humans at production and processing sites. This has to be taken into consideration for any classification decision for reproductive toxicity; especially a category 1 according to the EU CLP system is not warranted.

KW - Alveolar proteinosis

KW - Gallium arsenide

KW - Hemolysis

KW - Hypoxemia

KW - Inhalation

KW - Lung inflammation

KW - Mouse

KW - Rat

KW - Semiconductor

KW - Testicular atrophy

UR - http://www.scopus.com/inward/record.url?scp=84863853870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863853870&partnerID=8YFLogxK

U2 - 10.1016/j.yrtph.2012.06.005

DO - 10.1016/j.yrtph.2012.06.005

M3 - Article

VL - 64

SP - 77

EP - 86

JO - Regulatory Toxicology and Pharmacology

JF - Regulatory Toxicology and Pharmacology

SN - 0273-2300

IS - 1

ER -